A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of NORSPAN (Buprenorphine) in Korean Patients With Spinal Disorders (NOBLE)
Latest Information Update: 24 Oct 2015
Price :
$35 *
At a glance
- Drugs Buprenorphine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Acronyms NOBLE
- Sponsors Mundipharma International
- 21 Sep 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 06 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Mar 2013 New trial record